Check 35,000+ stocks against 26 valuation models and 37 quality factors

Medco Energi Internasional Tbk (MEDC) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Medco Energi Internasional Tbk IDR 1,243, price IDR 1,465, upside -15.2%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? No
Add to watchlist

Energy · ID · ISIN ID1000053705

ME Thin data Sep 24, 2026

Medco Energi Internasional Tbk

MEDC · JK

Weak valuationQuality is weak on top of the rich price.

!Fair value 1,243 IDR · Overvalued (−15%)

!Quality 47/100

!Expensive Growth (revenue 5y +17.0 %/yr)

!Thin margins · 6.2% net margin (TTM)

!High debt · generates free cash flow

✓Ranks above peers (9/14)

!Moderate moat 45/100

!Evidence only low, so the estimate is less certain

!Weak on valuation: 13 out of 100

!Weak on past: 28 out of 100

26 models, one by oneBear 932.11 IDR to bull 1,554 IDR Growth analysisrevenue history, year by year Quality 47/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Medco Energi Internasional Tbk for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 355.50 IDR – 1,942 IDR · fair‑value band 932.11 IDR – 1,554 IDR · the 1,465 IDR price screens above the 1,243 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Medco Energi Internasional Tbk in your weekly email

Every Wednesday you see whether Medco Energi Internasional Tbk is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Medco Energi Internasional Tbk, together with its subsidiaries, explores for and produces oil and gas in Indonesia, Asia, Africa, the Middle East, and the United Kingdom. It operates through Exploration and Production of Oil and Gas; Services; Power; Chemicals; and Trading segments. The company operates an independent power producer in the gas, geothermal, and other renewables sectors, as well as manages a portfolio of onshore and offshore assets in the Middle East, Africa, and the Asia Pacific. It is also involved in copper and gold mining operations in Sumbawa and Nusa Tenggara; and providing operation and maintenance services, and support services for oil and gas activities. The company was formerly known as PT Medco Energi Corporation and changed its name to PT Medco Energi Internasional Tbk in 2000. The company was founded in 1980 and is headquartered in Jakarta, Indonesia. PT Medco Energi Internasional Tbk operates as a subsidiary of Pt Medco Daya Abadi Lestari.

Stock analysis

Medco Energi Internasional Tbk (MEDC) currently trades at 1,465 IDR, while our model-based Fair Value estimate is 1,243 IDR, implying the stock looks roughly 17.9% overvalued today.

Valuation

Bull case: the DCF Models group reads highest at a median of 1,953 IDR per share, and 12 of the 26 models we run sit above the 1,465 IDR price.

Bear case: the Earnings-Based group reads lowest at 532.63 IDR, and 14 of the 26 models stay below the price. Evidence for this calculation is low.

Scenario range: 932.11 IDR (bear) to 1,554 IDR (bull), the price of 1,465 IDR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 47/100 (below-average quality), in the Energy sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Medco Energi Internasional Tbk reported revenue of $2.4B in FY2025 versus $1.3B in FY2021, a compound +16.0%/yr. Reported net income was $101M in FY2025, compounding +21.0%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.

Key figures

Market cap 36.2T IDR (≈ $3.6B) · P/E ratio 13.3 · P/S ratio 0.56 · EPS (TTM) 109.84 IDR · Net margin 4.2% · Return on equity 7.0% · Return on assets (EBIT) 12.1% · Operating margin 25.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (medium confidence).

What moves the price

The share trades about 25% below its 52-week high and 43% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Energy peers we cover trades at 10% fair-value upside, at −15%, MEDC screens richer than that median.

Fair Value models

Bear 932.11 IDR Fair Value 1,243 IDR Bull 1,554 IDR

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (80.35 IDR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF 2,663 IDR 5,149 IDR 8,877 IDR 77

Growth DCF 2,663 IDR 4,794 IDR 7,989 IDR 76

Residual Income 1,243 IDR 1,243 IDR 1,065 IDR 76

All 26 models by family

DCF Models

FCF DCF 2,663 IDR 5,149 IDR 8,877 IDR 77

Owner Earnings 532.63 IDR 1,953 IDR 4,084 IDR 70

5Y Revenue Exit 532.63 IDR 1,598 IDR 2,841 IDR 68

5Y EBITDA Exit 1,953 IDR 4,261 IDR 6,924 IDR 72

5Y P/E Exit 177.54 IDR 710.18 IDR 1,243 IDR 66

10Y Revenue Exit 1,243 IDR 2,308 IDR 3,728 IDR 65

10Y EBITDA Exit 2,131 IDR 4,084 IDR 6,747 IDR 66

10Y P/E Exit 1,065 IDR 1,775 IDR 2,663 IDR 63

Earnings-Based

Graham-Dodd 532.63 IDR 1,598 IDR 2,131 IDR 65

Lynch FV 355.09 IDR 532.63 IDR 710.18 IDR 61

PEG = 1.0 355.09 IDR 532.63 IDR 710.18 IDR 57

EPV 710.18 IDR 1,065 IDR 1,420 IDR 72

Dividend Discount

Gordon GGM 532.63 IDR 1,065 IDR 1,598 IDR 67

DDM Multi-Stage 532.63 IDR 887.72 IDR 1,065 IDR 67

Multiples

P/E Multiple 710.18 IDR 1,065 IDR 1,243 IDR 63

P/S Multiple 887.72 IDR 1,243 IDR 1,598 IDR 58

P/B Multiple 887.72 IDR 1,243 IDR 1,598 IDR 55

EV/EBIT 1,775 IDR 3,018 IDR 4,261 IDR 64

EV/EBITDA 2,131 IDR 3,373 IDR 4,794 IDR 65

EV/Revenue n/a 177.54 IDR 710.18 IDR 50

Asset-Based

NCAV (Graham) 710.18 IDR 1,065 IDR 1,598 IDR 53

Growth DCF

Growth DCF 2,663 IDR 4,794 IDR 7,989 IDR 76

Rev-Margin DCF 532.63 IDR 1,598 IDR 2,841 IDR 68

Economic Profit

Residual Income 1,243 IDR 1,243 IDR 1,065 IDR 76

ROIC Compounder 710.18 IDR 1,065 IDR 1,420 IDR 71

Growth Earnings

Growth-Adj P/E 710.18 IDR 887.72 IDR 1,243 IDR 67

Open the full fair value analysis →

Notify me when MEDC reaches fair value

Put MEDC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 47/100

Of which business quality 47 · Market factors (momentum, volatility) 55

Profitability 23

Margins and returns on capital today

Quality Growth 25

Are margins and returns improving?

Cashflow 71

Earnings quality: real cash, not paper profit

Fin. Strength 36

Balance sheet, leverage, solvency risk

Investment 37

Disciplined investing over empire-building

Low Volatility 60

Calm price path (market factor)

Momentum 53

Price trend over the last 3–12 months (market factor)

52W Momentum 50

Distance to the 52-week high (market factor)

Net Issuance 92

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100

The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Revenue growth 1 year

−0.2%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+1.2%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+17.0%

Start year 2020 (pandemic). Over 10 years: +14.3% a year

Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−24.9%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.

+16.9%

Earnings growth per share plus dividend.

Earnings per share, growth per year+16.9%

Dividend (yield on the price)0.0%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.17% vs −3%, picking up

Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.27% → 29%

Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price

The price assumes less growth than the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+8.4%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+1.7%

Yearly sales growth analysts expect, extended to five years.

After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +5.9% a year for the price and −0.7% for the forecasts.

Forecast 2026 (sales)+12.7%

Forecast 2027 (sales)−1.6%

Projected 2028 (sales)−1.1%

Projected 2029 (sales)−0.7%

Projected 2030 (sales)−0.2%

MEDC screens 18% overvalued. Compare with CNOOC Limited →

Compare Medco Energi Internasional Tbk with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas E&P · 306 stocks

Beats the industry median on 9/14 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 47 · Above median

Fair Value upside −15% · Below median

Profitability

Return on equity (TTM) 7% · Above median

Return on assets 5% · Above median

Net margin (TTM) 6% · Below median

Operating margin (TTM) 25% · Above median

Growth and dividend

Revenue growth 19% · Above median

Balance sheet

Debt / equity 1.53× · Highest 25%

Valuation Multiplesvs Oil & Gas E&P median · lower = cheaper

P/E (TTM) 13.3× · Cheaper than median

P/B 1.68× · Pricier than median

P/S (TTM) 1.48× · Cheaper than median

P/FCF 9.2× · Cheaper than median

EV/EBITDA 5.9× · Pricier than median

PEG 0.81× · Cheaper than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)13 · sector 29

FUTURE (revenue growth)96 · sector 12

PAST (return on equity)28 · sector 10

HEALTH (low debt)23 · sector 86

DIVIDEND (yield)0 · sector 73

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Oil & gas

Similar stocks

10 more Oil & Gas E&P stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
CNOOC Limited 0883	HK$23.68	HK$39.95	+69%
ConocoPhillips explores for, COP	$125.27	$90.15	−28%
Canadian Natural Resources Limited CNQ	$47.77	$52.55	+10%
EOG Resources, Inc EOG	$139.52	$165.02	+18%
Occidental Petroleum Corporation OXY	$56.31	$33.34	−41%
Diamondback Energy, Inc FANG	$184.50	$242.64	+32%
Devon Energy Corporation DVN	$46.93	$51.62	+10%
Woodside Energy Group WDS	A$31.13	A$23.59	−24%
EQT Corporation EQT	$50.81	$55.89	+10%
Texas Pacific Land Corporation TPL	$355.24	$318.28	−10%

Explore undervalued stocks

More undervalued Energy stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Medco Energi Internasional Tbk · Fair Value
1,243 IDR −18%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/MEDC" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Medco Energi Internasional Tbk · Fair Value</span><br><b style="font-size:20px">1,243 IDR</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−18%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Medco Energi Internasional Tbk Fair Value". https://www.fairvalue-calculator.com/stock/MEDC

Frequently asked questions

Is Medco Energi Internasional Tbk (MEDC) overvalued or undervalued?

As of Sep 24, 2026, our model estimates a fair value of 1,243 IDR versus a price of 1,465 IDR, about −15% upside (overvalued).

What is the fair value of MEDC?

Our model-based fair value for Medco Energi Internasional Tbk is 1,243 IDR (as of Sep 24, 2026), built from audited fundamentals. The current price: 1,465 IDR.

What is the quality score of MEDC?

Medco Energi Internasional Tbk has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Medco Energi Internasional Tbk (MEDC)?

Our model-based price target is the fair value of 1,243 IDR (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 932.11 IDR, optimistic scenario 1,554 IDR. It is a calculation from audited fundamentals, not an analyst target.

What is the Medco Energi Internasional Tbk stock forecast for 2026?

Our models put fair value at 1,243 IDR, about −15% upside versus a price of 1,465 IDR (overvalued). Cautious scenario 932.11 IDR, optimistic scenario 1,554 IDR. The calculation is refreshed regularly with new filings.

What is the revenue of Medco Energi Internasional Tbk (MEDC)?

Medco Energi Internasional Tbk reported trailing-twelve-month revenue of about $2.4B (latest available figure, as of Sep 24, 2026).

What growth is priced into Medco Energi Internasional Tbk (MEDC)?

For today's price to be fair in a discounted-cash-flow model, Medco Energi Internasional Tbk would have to grow free cash flow by +8.4 % per year for five years (discount rate 10.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +17.0 % per year. As of Sep 24, 2026.

What discount rate (WACC) does the fair value of MEDC use?

Our models discount Medco Energi Internasional Tbk at 10.5 %: a base by market capitalisation (mid), damped by beta 0.13, country premium for Indonesia. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Medco Energi Internasional Tbk that is +8.4 % per year a year over ten years, using the same discount rate (10.5 %) and the same formula as our fair value.

How much growth has Medco Energi Internasional Tbk (MEDC) delivered so far?

Over the past 5 years revenue at Medco Energi Internasional Tbk grew +17.0 % a year. The price currently implies +8.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Medco Energi Internasional Tbk (MEDC) growing?

The median revenue growth in the sector is +1.8 % a year. That is the yardstick for the growth priced into Medco Energi Internasional Tbk (+8.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Medco Energi Internasional Tbk (MEDC)?

The free-cash-flow yield on the price is 10.81 %: that much free cash flow Medco Energi Internasional Tbk produces per unit of market value. When it exceeds the discount rate of our models (10.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Medco Energi Internasional Tbk (MEDC)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Medco Energi Internasional Tbk it is 1,243 IDR per share (as of Sep 24, 2026), against a price of 1,465 IDR. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).

Is Medco Energi Internasional Tbk stock overvalued or undervalued in 2026?

As of Sep 24, 2026, MEDC trades above its calculated fair value: price 1,465 IDR, fair value 1,243 IDR, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of MEDC?

No. The price is what the market pays today (1,465 IDR); the fair value is what the company's own numbers justify (1,243 IDR). For Medco Energi Internasional Tbk the two are 222.19 IDR per share apart. That gap is exactly why we show both numbers side by side.

How much is Medco Energi Internasional Tbk worth?

The market values Medco Energi Internasional Tbk at about 36.2T IDR (market capitalisation, as of Sep 24, 2026). Per share that is 1,465 IDR; our models calculate a fair value of 1,243 IDR per share.

What do the bullish and bearish scenarios say about MEDC?

Our models span a range for Medco Energi Internasional Tbk: cautious scenario 932.11 IDR, base 1,243 IDR, optimistic 1,554 IDR per share (as of Sep 24, 2026, price 1,465 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of MEDC?

Medco Energi Internasional Tbk trades at a price-to-earnings ratio of 13.3 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1,243 IDR is built from several models across several years. Other multiples: PEG 0.8, P/B 1.7, P/S 1.5, EV/EBITDA 5.9.

What is the PEG ratio of MEDC?

The PEG ratio of Medco Energi Internasional Tbk is 0.81 (P/E divided by earnings growth, as of Sep 24, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.

How solid is the balance sheet of Medco Energi Internasional Tbk (MEDC)?

Balance-sheet figures for Medco Energi Internasional Tbk (as of Sep 24, 2026): return on equity 7.0%, debt of 1.53 per unit of equity. They feed the Quality Score of 47/100, which measures business quality independently of the share price.

How far is MEDC from its 52-week high?

Medco Energi Internasional Tbk trades at 1,465 IDR, about 25% below its 52-week high of 1,942 IDR and 43% above the low of 1,025 IDR (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 1,243 IDR is for.

Which stocks are comparable to Medco Energi Internasional Tbk?

From the same area (Energy) we also value CNOOC Limited, ConocoPhillips explores for,, Canadian Natural Resources Limited, EOG Resources, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Medco Energi Internasional Tbk stock attractive at the current price?

The data as of Sep 24, 2026: price 1,465 IDR, calculated fair value 1,243 IDR (−15%), Quality Score 47/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of MEDC calculated?

We run Medco Energi Internasional Tbk through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1,243 IDR, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.1 % above its aggregate fair value. Medco Energi Internasional Tbk itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Medco Energi Internasional Tbk (MEDC)?

The closing price on Sep 23, 2026 was 1,465 IDR. Our model-based fair value is 1,243 IDR, about −15% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Medco Energi Internasional Tbk right now?

Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Where does the earnings growth of Medco Energi Internasional Tbk (MEDC) come from?

Earnings per share at Medco Energi Internasional Tbk grew +7.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share +10.1 %, EBIT margin +3.5 %, tax rate −1.8 %, residual (interest, one-offs) −4.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Medco Energi Internasional Tbk

How large is the market capitalisation of Medco Energi Internasional Tbk (MEDC)?

The market capitalisation of Medco Energi Internasional Tbk is 36.2T IDR (≈ $3.6B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Medco Energi Internasional Tbk (MEDC)?

The price-to-sales ratio of Medco Energi Internasional Tbk is 0.56 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Medco Energi Internasional Tbk (MEDC)?

Earnings per share at Medco Energi Internasional Tbk are 109.84 IDR (price ÷ EPS = P/E 13.3). Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Medco Energi Internasional Tbk (MEDC)?

The net margin of Medco Energi Internasional Tbk is 4.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Medco Energi Internasional Tbk (MEDC)?

The return on equity (ROE) of Medco Energi Internasional Tbk is 7.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Medco Energi Internasional Tbk (MEDC)?

On an EBIT basis the return on assets of Medco Energi Internasional Tbk is 12.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Medco Energi Internasional Tbk (MEDC)?

The operating margin of Medco Energi Internasional Tbk is 25.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Medco Energi Internasional Tbk (MEDC)?

Revenue at Medco Energi Internasional Tbk is growing +19.2% versus a year earlier (3y avg +1.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Medco Energi Internasional Tbk (MEDC)?

Earnings per share at Medco Energi Internasional Tbk are growing +288% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Medco Energi Internasional Tbk (MEDC) carry?

The net debt of Medco Energi Internasional Tbk is $3.3B (fiscal year 2025, ≈ 8.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Medco Energi Internasional Tbk in the live analysis

One click puts Medco Energi Internasional Tbk on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.